Not actual size and may not represent exact color.
Checking your medicine allows you to determine if you’ve been given CellCept as prescribed by your doctor.
Do you know the branded CellCept characteristics?
CellCept® (mycophenolate mofetil) is a medicine given by prescription to people who had a kidney, heart or liver transplant. CellCept can help prevent rejection of the new organ.
Your body's immune system can tell that the new heart, liver or kidney is different and tries to reject it. CellCept is taken along with other anti-rejection medicines to help control your immune system. They help keep it from "rejecting" the transplant.
Follow your doctor's exact orders for taking CellCept and all other medicines.
You should have one pregnancy test immediately before starting CellCept and another pregnancy test 8 to 10 days later. Pregnancy tests should be repeated during routine follow-up visits with your doctor. Talk to your doctor about the results of all of your pregnancy tests.
If you are a woman who can get pregnant, you must use acceptable birth control during your entire CellCept therapy, and continue birth control for 6 weeks after you stop taking CellCept, unless you choose to abstain from sexual intercourse with a man completely. Talk to your doctor about other birth control methods that you can use while taking CellCept.
If you plan to become pregnant, talk with your doctor. You and your doctor can decide if other medicines to prevent rejection may be right for you.
If you become pregnant while taking CellCept, do not stop taking CellCept. Call your doctor right away. In certain situations, you and your doctor may decide that taking CellCept is more important to your health than the possible risks to your unborn baby.
People taking high doses of CellCept each day may have a decrease in blood counts, including white blood cells, red blood cells and platelets.
Your doctor will do blood tests before you start taking CellCept and during therapy with CellCept to check your blood cell counts.
Tell your doctor right away if you have any signs of infection, or any unexpected bruising or bleeding, unusual tiredness, lack of energy, dizziness or fainting.
The most common side effects include: diarrhea, vomiting, pain, stomach area pain, swelling of the lower legs, ankles and feet, and high blood pressure.
These are not all of the possible side effects of CellCept. Tell your doctor about any side effect that bothers you or that does not go away.
This important safety information does not take the place of talking with your doctor about your medical condition or your treatment. Talk with your doctor if you have any questions about your health problems or treatment.
Please see full Prescribing Information, including Boxed WARNING and Medication Guide, for additional Important Safety Information.
The information contained in this section of the site is intended for US healthcare professionals only. Click “Proceed” if you are a healthcare professional.Proceed
By using the CellCept® Co-pay Card Program, the patient acknowledges and confirms that at the time of usage, he/she is currently eligible and meets the criteria set forth in the Terms and Conditions described.
This Co-pay Card is valid ONLY for patients with commercial (private or non-governmental) insurance. It is not valid for patients who are government beneficiaries or whose medications are covered, in whole or in part, under Medicaid, Medicare Parts A, B, C, and/or D, TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan, or any other state or federal healthcare program. Patients who become government beneficiaries during their enrollment period will no longer be eligible for the program as of the date they become government beneficiaries.
This Co-pay Card program is not health insurance or a benefit plan. Distribution or use of the Co-pay Card does not obligate use or continuing use of any specific product or provider. Patient or guardian is responsible for reporting the receipt of all Co-pay Card program benefits or reimbursement received to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Co-pay Card program, as may be required.
The Co-pay Card is not valid for medications the patient receives for free or that are eligible to be reimbursed by private insurance plans or other healthcare or pharmaceutical assistance programs (such as GATCF or any other charitable organization) that reimburse the patient in part or for the entire cost of his/her medication. Patient, guardian, pharmacist, prescriber, and any other person using the Co-pay Card agree not to seek reimbursement for all or any part of the benefit received by the recipient through the offer.
The Co-pay Card will be accepted by participating pharmacies, physician offices, or hospitals. To qualify for the benefits of this Co-pay Card program, the patient may be required to pay out-of-pocket expenses for each treatment. Once the patient is enrolled, this Co-pay Card program will not honor claims with dates of service or medication dispensing that precede program enrollment by more than 120 days. This Co-pay Card is only available with a valid prescription and cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. Use of this Co-pay Card must be consistent with all relevant health insurance requirements and payer agreements. Participating patients, pharmacies, physician offices, and hospitals are obligated to inform third-party payers about the use of the Co-pay Card as provided for under the applicable insurance or as otherwise required by contract or law. The Co-pay Card may not be sold, purchased, traded, or offered for sale, purchase, or trade. The Co-pay Card is limited to 1 per person during this offering period and is not transferable. This program expires within 12 months from enrollment. This program is not valid where prohibited by law. For Massachusetts residents, the Co-pay Card is not valid for any prescription drug that has an AB-rated generic equivalent as determined by the United States Food and Drug Administration. For Massachusetts residents, this program shall expire on or before July 1, 2017.
The patient or their guardian must be 18 years or older to receive Co-pay Card program assistance. This Co-pay Card program is: (1) void if the card is reproduced; (2) void where prohibited by law; (3) only valid in the United States and Puerto Rico; and (4) only valid for Genentech products. Healthcare providers may not advertise or otherwise use the program as a means of promoting their services or Genentech’s products to patients. Genentech, Inc., reserves the right to rescind, revoke, or amend the program without notice at any time.